Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
Clinical trial NCT01873950 · COMPLETED
Trial details
- NCT number
- NCT01873950
- Sponsor
- Food and Drug Administration (FDA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-07-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.